Cbsbioscience Co., Ltd
Daejeon, KR· latest recorded location
CBSBIOSCIENCE CO., LTD is named on 0 US grants and 5 published applications in this corpus. Its most frequent classification is C12Q (Measuring or testing processes involving enzymes, nucleic acids or microorganisms).
- Granted patents
- 0
- Published applications
- 5
- Inventors
- 18
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 5 documents
Recent patents
No granted patents yet.
- Methods and compositions for predicting and treating triple negative breast cancer16 Jul 2026US 2026/0201473 A1
- Analysis method for increasing susceptibility to sorafenib treatment in hepatocellular carcinoma16 Mar 2023US 2023/0081529 A1
- Analysis method for prediction of response to preoperative chemoradiotherapy in rectal cancer patient16 Mar 2023US 2023/0084335 A1
- Method for predicting sensitivity to vascular endothelial growth factor receptor inhibitor1 Feb 2018US 2018/0030541 A1
- Method for predicting receptivity to targeted anticancer drug14 Dec 2017US 2017/0356048 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.